Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC-ND 4.0Plastic and Reconstructive Surgery Global Open

Opioid-sparing Pain Management for Pediatric Alveolar Bone Grafting: Efficacy of the Bupivacaine-soaked Absorbable Sponge

8 affiliations
  1. 1From the Division of Plastic and Reconstructive Surgery, The Hospital for Sick Children, Toronto, Ontario, Canada
  2. 2Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  3. 3Department of Plastic Surgery, Rwanda Military Hospital, Kigali, Rwanda
  4. 4Division of Plastic, Reconstructive and Aesthetic Surgery, Department of Surgery, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
  5. 5Department of Anesthesiology & Pain Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
  6. 6Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada
  7. 7Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
  8. 8Child Health and Evaluative Sciences, SickKids Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.

Abstract

Background:: The iliac crest is the gold-standard donor site for alveolar bone grafting, yet donor-site pain often leads to increased opioid use and prolonged hospital stays. This study evaluates whether the adjunctive use of bupivacaine-soaked absorbable sponge in addition to subcutaneous local anesthesia infiltration provides improved postoperative pain management compared with local anesthetic alone.

Methods:: Medical records of consecutive patients who underwent alveolar bone grafting between January 2023 and September 2024 were retrospectively reviewed. Patients were grouped based on whether they received bupivacaine-soaked absorbable sponge with local anesthetic (sponge group, N = 28) or subcutaneous local anesthetic alone (no-sponge group, N = 38). The primary outcome measure was postoperative opioid consumption. Secondary outcomes included nonopioid analgesic use, hospital length of stay, and discharge opioid prescriptions.

Results:: Sixty-six patients with comparable baseline demographics were analyzed. Multivariable regression revealed significantly lower opioid consumption on postoperative day 0 in the sponge group compared with the no-sponge group (−0.14 mg/kg oral morphine equivalents; P = 0.04). Furthermore, all no-sponge group patients required supplemental nonopioid analgesics on postoperative day 0, compared with 82% of patients in the sponge group (P = 0.01). No significant differences were observed between groups in hospital length of stay, discharge opioid prescriptions, and opioid or nonopioid analgesic use beyond postoperative day 0.

Conclusions:: The application of bupivacaine-soaked absorbable sponge at the iliac crest donor site is a simple, inexpensive, and effective method for enhancing immediate postoperative pain management in pediatric patients undergoing alveolar bone grafting compared with subcutaneous local anesthetic alone.

Related

  1. Tract embolization using absorbable gelatin sponge torpedoes following transsplenic or transhepatic access in pediatric patients
    Mert Bayramoğlu, Yunus Emre Şentürk, Enes Muhammed Cantürk +2
    Diagnostic and Interventional RadiologyPeer-reviewedCC BY-NC 4.0Full textGeneral medicinePMCDOAJ
  2. Comparison of Effectiveness of Caudal Dexmedetomidine vs. Caudal Fentanyl with Bupivacaine during Pediatric Cardiac Surgery with regards to Hemodynamic Fluctuations and Postoperative Pain
    Roshani Nitin Manwani, Dhawal Wadaskar, Prasad Panbude +2
    Annals of Cardiac AnaesthesiaPeer-reviewedCC BY-NC-SA 4.0Full textSurgery & anaesthesiaPMC
  3. Bupivacaine-Loaded PLGA Nanoparticles for Long-Term Management of Chronic Neuropathic Pain.
    Tao Wang, Keyun Tang, Fengrun Sun +5
    PharmaceuticsPeer-reviewedCC BYFull textPhysiologyEurope PMC
  4. Evaluation of Intraperitoneal Instillation Combined with Port-Site Infiltration of 0.5% Bupivacaine for Postoperative Pain Management in Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial
    Anmol Gupta, Surya Prakash, Pankaj Kumar Saunakiya +1
    International Journal of Medical Sciences and Academic ResearchPeer-reviewedCC BYFull textGeneral medicineDOAJ
  5. Vitamins in the Management of Inferior Alveolar Nerve Sensory Disturbances: A Scoping Review of Randomized Studies
    Wojciech Macek, Maciej Chęciński, Kamila Chęcińska +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{tang2026opioidsparing,
  title = {{Opioid-sparing Pain Management for Pediatric Alveolar Bone Grafting: Efficacy of the Bupivacaine-soaked Absorbable Sponge}},
  author = {Eileen A. Tang and Dorna Ravamehr-Lake and Yves Nezerwa and Farrukh Munshey and Kariym Joachim and David M. Fisher and John H. Phillips and Dale J. Podolsky and Johanna N. Riesel and Karen W.Y. Wong Riff},
  journal = {Plastic and Reconstructive Surgery Global Open},
  year = {2026},
  month = nov,
  doi = {10.1097/gox.0000000000008233},
  url = {https://doi.org/10.1097/gox.0000000000008233},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Opioid-sparing Pain Management for Pediatric Alveolar Bone Grafting: Efficacy of the Bupivacaine-soaked Absorbable Sponge
AU  - Eileen A. Tang
AU  - Dorna Ravamehr-Lake
AU  - Yves Nezerwa
AU  - Farrukh Munshey
AU  - Kariym Joachim
AU  - David M. Fisher
AU  - John H. Phillips
AU  - Dale J. Podolsky
AU  - Johanna N. Riesel
AU  - Karen W.Y. Wong Riff
PY  - 2026
DA  - 2026/11/12
JO  - Plastic and Reconstructive Surgery Global Open
DO  - 10.1097/gox.0000000000008233
UR  - https://doi.org/10.1097/gox.0000000000008233
AB  - Background:: The iliac crest is the gold-standard donor site for alveolar bone grafting, yet donor-site pain often leads to increased opioid use and prolonged hospital stays. This study evaluates whether the adjunctive use of bupivacaine-soaked absorbable sponge in addition to subcutaneous local anesthesia infiltration provides improved postoperative pain management compared with local anesthetic alone.  Methods:: Medical records of consecutive patients who underwent alveolar bone grafting between January 2023 and September 2024 were retrospectively reviewed. Patients were grouped based on whether they received bupivacaine-soaked absorbable sponge with local anesthetic (sponge group, N = 28) or subcutaneous local anesthetic alone (no-sponge group, N = 38). The primary outcome measure was postoperative opioid consumption. Secondary outcomes included nonopioid analgesic use, hospital length of stay, and discharge opioid prescriptions.  Results:: Sixty-six patients with comparable baseline demographics were analyzed. Multivariable regression revealed significantly lower opioid consumption on postoperative day 0 in the sponge group compared with the no-sponge group (−0.14 mg/kg oral morphine equivalents; P = 0.04). Furthermore, all no-sponge group patients required supplemental nonopioid analgesics on postoperative day 0, compared with 82% of patients in the sponge group (P = 0.01). No significant differences were observed between groups in hospital length of stay, discharge opioid prescriptions, and opioid or nonopioid analgesic use beyond postoperative day 0.  Conclusions:: The application of bupivacaine-soaked absorbable sponge at the iliac crest donor site is a simple, inexpensive, and effective method for enhancing immediate postoperative pain management in pediatric patients undergoing alveolar bone grafting compared with subcutaneous local anesthetic alone.
SN  - 2169-7574
ER  -